Levy Adam Scott
Insider CIK 1693134 · MGEN Chief Business Officer · MLYS CFO, Chief Bus. Off. and Secy. · BBI Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 53,300 | — | $0 | 53,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 39,900 | — | $0 | 48,538 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-12 | 2026-01-13 | 10,758 | $32.14 | $345.8K | 8,638 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-11-11 | 2025-11-13 | 20,547 | — | $0 | 135,674 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-11-11 | 2025-11-13 | 34,414 | — | $0 | 20,662 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-11-11 | 2025-11-13 | 44,079 | — | $0 | 91,592 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-11-11 | 2025-11-13 | 6,613 | — | $0 | 4,888 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-11-11 | 2025-11-13 | 6,613 | $15.44 | $102.1K | 138,920 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-11-11 | 2025-11-13 | 44,079 | $14.25 | $628.1K | 132,307 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 32,718 | $46.88 | $1.53M | 19,396 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-11-11 | 2025-11-13 | 20,547 | $10.20 | $209.6K | 53,814 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 1,015 | $42.00 | $42.6K | 137,905 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 11,295 | $41.87 | $472.9K | 126,610 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 1,561 | $42.68 | $66.6K | 125,049 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 12,952 | $41.65 | $539.5K | 112,097 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 8,485 | $42.34 | $359.3K | 103,612 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 4,142 | $43.50 | $180.2K | 99,470 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 8,456 | $45.18 | $382.0K | 91,014 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 38,900 | $45.93 | $1.79M | 52,114 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-11-11 | 2025-11-13 | 34,414 | $16.00 | $550.6K | 88,228 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-10-13 | 2025-10-15 | 3,392 | $42.26 | $143.3K | 116,865 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-10-13 | 2025-10-15 | 7,366 | $41.90 | $308.6K | 120,257 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-30 | 2025-07-30 | 8,425 | $15.10 | $127.2K | 132,934 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-30 | 2025-07-30 | 51,500 | $14.70 | $757.0K | 141,359 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-29 | 2025-07-30 | 807 | $14.00 | $11.3K | 192,859 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-28 | 2025-07-30 | 12,946 | $14.04 | $181.8K | 193,666 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-11 | 2025-07-15 | 10,758 | $14.45 | $155.5K | 206,612 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-11 | 2025-04-15 | 10,757 | $12.06 | $129.7K | 215,340 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 170,000 | — | $0 | 170,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-01-13 | 2025-01-15 | 100 | $9.63 | $963 | 226,097 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-01-13 | 2025-01-15 | 10,657 | $9.09 | $96.9K | 226,197 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-10-11 | 2024-10-15 | 10,757 | $13.57 | $146.0K | 236,854 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-07-11 | 2024-07-12 | 10,757 | $13.14 | $141.3K | 247,611 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-11 | 2024-06-13 | 96,815 | $12.94 | $1.25M | 255,462 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-02-13 | 2024-02-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-03-17 | 2023-03-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 6,250 | $16.00 | $100.0K | 350,811 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 97,518 | — | $0 | 97,518 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 20,000 | $1.54 | $30.8K | 20,000 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | A Award deriv | 2019-02-06 | 2019-02-08 | 74,000 | — | $0 | 74,000 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | P Buy | 2018-02-13 | 2018-02-13 | 9,090 | $5.50 | $50.0K | 10,540 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | A Award deriv | 2018-01-31 | 2018-02-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | P Buy | 2017-06-22 | 2017-06-23 | 200 | $7.55 | $1.5K | 200 | SEC↗ |
| MGEN MIRAGEN THERAPEUTICS, INC. | A Award deriv | 2017-02-16 | 2017-02-16 | 87,500 | — | $0 | 87,500 | SEC↗ |